B. Riley Has Negative View of Aspen Aerogels FY2027 Earnings

Aspen Aerogels, Inc. (NYSE:ASPN) – Stock analysts at B. Riley reduced their FY2027 earnings per share (EPS) estimates for shares of Aspen Aerogels in a report issued on Tuesday, November 5th. B. Riley analyst R. Pfingst now forecasts that the construction company will earn $1.64 per share for the year, down from their prior forecast of $1.79. The consensus estimate for Aspen Aerogels’ current full-year earnings is $0.10 per share.

Several other research analysts have also weighed in on the company. Roth Mkm reissued a “buy” rating and issued a $36.00 price objective on shares of Aspen Aerogels in a research report on Wednesday, August 21st. StockNews.com raised Aspen Aerogels to a “sell” rating in a research note on Thursday, October 31st. HC Wainwright reaffirmed a “buy” rating and set a $30.00 price objective on shares of Aspen Aerogels in a research report on Wednesday, October 16th. Benchmark reiterated a “buy” rating and issued a $14.00 price objective on shares of Aspen Aerogels in a research note on Thursday, August 8th. Finally, TD Cowen increased their target price on shares of Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a research note on Tuesday, August 20th. One investment analyst has rated the stock with a sell rating, nine have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $29.40.

Aspen Aerogels Stock Performance

NYSE ASPN opened at $18.51 on Wednesday. The company has a market capitalization of $1.43 billion, a price-to-earnings ratio of -1,851.00 and a beta of 2.21. The company has a quick ratio of 2.82, a current ratio of 3.46 and a debt-to-equity ratio of 0.23. Aspen Aerogels has a twelve month low of $8.58 and a twelve month high of $33.15. The stock has a fifty day simple moving average of $23.82 and a 200 day simple moving average of $24.71.

Aspen Aerogels (NYSE:ASPN) last posted its earnings results on Wednesday, August 7th. The construction company reported $0.21 earnings per share for the quarter, topping analysts’ consensus estimates of $0.05 by $0.16. The firm had revenue of $117.80 million for the quarter, compared to analyst estimates of $101.99 million. Aspen Aerogels had a net margin of 0.39% and a return on equity of 0.74%. The company’s revenue for the quarter was up 144.4% compared to the same quarter last year. During the same period in the previous year, the firm posted ($0.22) EPS.

Institutional Investors Weigh In On Aspen Aerogels

Several large investors have recently made changes to their positions in ASPN. BNP Paribas Financial Markets raised its holdings in shares of Aspen Aerogels by 85.2% in the 1st quarter. BNP Paribas Financial Markets now owns 25,706 shares of the construction company’s stock worth $452,000 after purchasing an additional 11,823 shares during the period. GSA Capital Partners LLP purchased a new stake in Aspen Aerogels in the 1st quarter worth about $1,181,000. Oppenheimer & Co. Inc. bought a new stake in Aspen Aerogels in the 1st quarter valued at about $388,000. Swiss National Bank lifted its holdings in Aspen Aerogels by 16.2% during the first quarter. Swiss National Bank now owns 120,500 shares of the construction company’s stock valued at $2,121,000 after purchasing an additional 16,800 shares during the last quarter. Finally, Vanguard Group Inc. boosted its position in Aspen Aerogels by 5.1% during the first quarter. Vanguard Group Inc. now owns 3,619,702 shares of the construction company’s stock worth $63,707,000 after purchasing an additional 175,906 shares during the period. 97.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Aspen Aerogels

In related news, CEO Donald R. Young sold 63,355 shares of the stock in a transaction on Monday, September 30th. The stock was sold at an average price of $30.03, for a total value of $1,902,550.65. Following the completion of the sale, the chief executive officer now directly owns 483,640 shares of the company’s stock, valued at approximately $14,523,709.20. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Aspen Aerogels news, CEO Donald R. Young sold 63,355 shares of Aspen Aerogels stock in a transaction that occurred on Monday, September 30th. The shares were sold at an average price of $30.03, for a total transaction of $1,902,550.65. Following the transaction, the chief executive officer now owns 483,640 shares of the company’s stock, valued at $14,523,709.20. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Ricardo C. Rodriguez sold 32,465 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $30.14, for a total value of $978,495.10. Following the completion of the transaction, the chief financial officer now owns 20,790 shares in the company, valued at $626,610.60. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 4.30% of the stock is owned by insiders.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.